Course detailHarvardGraduatewaitlist

BIOT E-220

Regulatory Aspects of Drug Development

The course provides an overview of the prescription drug development process and regulatory considerations for this process, including small molecules, biologics, and gene therapy.

It focuses on the phases of pharmaceutical development, aspects influencing the pharmaceutical industry, and the regulatory themes and health-care concepts that shape the decisions having an impact on the entire process.

Schedule note
Th 8:10pm - 10:10pm Jan 25 to May 16